中草藥治療哮喘的免疫調節作用最新研究進展
發布時間:2019-08-07 10:00
【摘要】:哮喘是由多種免疫細胞參與的慢性呼吸道炎癥疾病,常常導致氣促、胸悶、咳嗽以及反復發作的喘息等癥狀,往往出現氣流阻塞,影響人體健康。中草藥(CHM)用于治療哮喘已經有上千年的歷史,大量研究表明中草藥能有效的調節細胞免疫反應減緩哮喘癥狀。該文綜述了近幾年來中草藥對免疫細胞的調節作用及相關分子機制的研究,包括炎癥細胞數量、樹突狀細胞成熟、輔助性T細胞亞型之間的平衡、調節性T細胞的誘導及胞內信號通路,并展望了未來的研究方向。
[Abstract]:Asthma is a chronic airway inflammation disease, which is involved in many immune cells, which often leads to the symptoms of shortness of breath, chest distress, cough, and wheezing and other symptoms, and the air flow is often blocked and the health of the human body is affected. Chinese herbal medicine (CHM) has been used in the treatment of asthma, and a large number of studies have shown that the Chinese herbal medicine can effectively regulate cellular immune response and slow the symptoms of asthma. The effects of Chinese herbal medicines on immune cells and related molecular mechanisms in recent years have been reviewed, including the number of inflammatory cells, the maturation of dendritic cells, the balance between the helper T-cell subtypes, the induction of regulatory T cells and the intracellular signaling pathway, And the future research direction is also looked forward.
【作者單位】: 新疆生物資源基因工程重點實驗室新疆大學生命科學與技術學院;烏魯木齊市第二十三中學;
【基金】:國家自然科學基金項目(31460241)
【分類號】:R256.12
[Abstract]:Asthma is a chronic airway inflammation disease, which is involved in many immune cells, which often leads to the symptoms of shortness of breath, chest distress, cough, and wheezing and other symptoms, and the air flow is often blocked and the health of the human body is affected. Chinese herbal medicine (CHM) has been used in the treatment of asthma, and a large number of studies have shown that the Chinese herbal medicine can effectively regulate cellular immune response and slow the symptoms of asthma. The effects of Chinese herbal medicines on immune cells and related molecular mechanisms in recent years have been reviewed, including the number of inflammatory cells, the maturation of dendritic cells, the balance between the helper T-cell subtypes, the induction of regulatory T cells and the intracellular signaling pathway, And the future research direction is also looked forward.
【作者單位】: 新疆生物資源基因工程重點實驗室新疆大學生命科學與技術學院;烏魯木齊市第二十三中學;
【基金】:國家自然科學基金項目(31460241)
【分類號】:R256.12
【相似文獻】
相關期刊論文 前10條
1 夏紹軍;中醫藥與腫瘤的免疫調節概述[J];中醫藥臨床雜志;2004年04期
2 蔣保祥;影響中藥免疫調節因素的探討[J];江蘇中醫;1999年05期
3 胡聰;“免疫調節中藥”述要[J];四川中醫;1998年01期
4 郭紅云;劉秀玉;;中藥治療復發性阿弗他潰瘍免疫調節與療效觀察[J];中國民康醫學;2006年12期
5 馮立;張敏;;試論腎脾肺在妊娠免疫調節中的作用[J];浙江中醫學院學報;1993年06期
6 王甜甜;韓倩倩;吳芳;朱艷琴;;中藥對腫瘤患者的免疫調節[J];光明中醫;2014年03期
7 周青山;賈新亭;田保利;;整體免疫調節防治艾滋病多發性感染[J];中國中醫藥信息雜志;2008年S1期
8 趙U,
本文編號:2523882
本文鏈接:http://www.malleg.cn/zhongyixuelunwen/2523882.html

